Funding Details
- Awarder
- Gaingels
- Date Award
- May 24, 2024
- Vertical
- Healthcare and Biotech
- Funding URL
- View Funding Page
- Valuation
-
$60,000,000
Company Info
- Founders
- Kevin Eisenfrats
- Company Description
- A medical device company creating injectable hydrogel designed to provide men with long-lasting contraception. Contraline is developing the first long-lasting, non-hormonal, reversible contraceptive for men
- Market
- Healthcare & Wellness
- Coinvestors
- VU Venture Partners
Links